112. Thalassemia and Globin Gene Regulation: Poster III

Luspatercept for the Treatment of Anemia in Non-Transfusion-Dependent ß-Thalassemia: Final Safety and Efficacy Data from the BEYOND Trial

Efficacy and Safety of Luspatercept in Patients with HbE/ß-Thalassemia from the BELIEVE Study: A Subgroup Analysis

Efficacy and Safety of Luspatercept in Patients Enrolled in the BELIEVE Trial: Data from the Phase 3b Long-Term Rollover Study

Mitapivat Treatment Increases ß-Thalassemic Erythroblasts Energy Production and Responsiveness to Oxidative Stress

Bone Marrow Sinusoidal Endothelial Cells Are a Site of Fgf23 Upregulation in Murine ß-Thalassemia

Alterations of Plasma Metabolomics Profile in Thalassemia Patients with Low Bone Mineral Density